Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Mar 24, 2023; 14(3): 99-116
Published online Mar 24, 2023. doi: 10.5306/wjco.v14.i3.99

Full Size Figure Download Figure

Figure 2 Diagnostic algorithm of Budd-Chiari syndrome due to myeloproliferative neoplasms.

Citation: Găman MA, Cozma MA, Manan MR, Srichawla BS, Dhali A, Ali S, Nahian A, Elton AC, Simhachalam Kutikuppala LV, Suteja RC, Diebel S, Găman AM, Diaconu CC. Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature. World J Clin Oncol 2023; 14(3): 99-116
URL: https://www.wjgnet.com/2218-4333/full/v14/i3/99.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i3.99

Găman MA, Cozma MA, Manan MR, Srichawla BS, Dhali A, Ali S, Nahian A, Elton AC, Simhachalam Kutikuppala LV, Suteja RC, Diebel S, Găman AM, Diaconu CC. Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature. World J Clin Oncol 2023; 14(3): 99-116 [PMID: 37009527 DOI: 10.5306/wjco.v14.i3.99]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.